A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Phenytoin/Free Phenytoin
Test CodeLAB4072
Alias/See Also
PTN/ Free PTN;Dilantin/Free Dilantin
Preferred Specimen
4.5 ml (4.5 ml min) lithium heparin (green); alternate-SST (gold) or Red (no additive)
Minimum Volume
2 ml plasma; alternate-serum
Other Acceptable Specimens
Gold SST
Instructions
Separate from cells ASAP. After centrifugation, if not in gel barrier tube, pour off plasma into an aliquot tube
Transport Temperature
Room Temp
Specimen Stability
Separated from cells: 1 month refrigerated
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Icteric: >30 mg/dL bilirubin, Hemolysis: >800 mg/dL hemoglobin, Lipemia: >750 mg/dL triglycerides
Methodology
Fluorescent Polarization Immunoassay (FPIA), Immunoassay
Setup Schedule
Mon- Sun
Reference Range
Reference Range 1.0-2.0 μg /ml
Toxic >/= 3.0 μg /ml
Toxic >/= 3.0 μg /ml
Clinical Significance
The total concentrations of the drug in the blood consist of the protein-bound fraction and the free fraction, of which only the free
drug is considered to be pharmacologically active. Due to the fact that phenytoin is highly bound to plasma proteins (89-95%),
any alteration in the protein binding of phenytoin due to uremia, hypoalbuminemia, and ingestion of other drugs or age can result
in a significantly different clinical response to a total phenytoin
drug is considered to be pharmacologically active. Due to the fact that phenytoin is highly bound to plasma proteins (89-95%),
any alteration in the protein binding of phenytoin due to uremia, hypoalbuminemia, and ingestion of other drugs or age can result
in a significantly different clinical response to a total phenytoin
Performing Laboratory
Piedmont Athens Regional